Clinical • PD(L)-1 Biomarker • IO biomarker
|
HER-2 (Human epidermal growth factor receptor 2) • PD-L1 (Programmed death ligand 1) • KRAS (KRAS proto-oncogene GTPase) • ER (Estrogen receptor) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • MSI (Microsatellite instability) • FGFR2 (Fibroblast growth factor receptor 2) • FGFR3 (Fibroblast growth factor receptor 3) • ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3)
|
PD-L1 expression • KRAS mutation • HER-2 amplification • PIK3CA mutation • MET amplification • FGFR2 mutation • NF1 mutation • FGFR2 amplification • FGFR3 mutation • KRAS G12A • PIK3CA amplification • HER-2 S310F • HER-2 V777L • KRAS G12 • KRAS G13 • NF2 mutation • ERBB3 mutation • HER-2 L869R • ERBB3 G284R • FGFR3 amplification
|
Herceptin (trastuzumab)